ÂÜÀòÂÒÂ×

Mark McKenna currently holds various executive positions in the biotechnology and pharmaceutical industries. With a strong background in sales, operations, and business development, Mark has demonstrated leadership in companies such as Mirador Therapeutics, Apogee Therapeutics, and Prometheus Biosciences. Mark also has experience in strategic planning and revenue management in roles at Bausch + Lomb and Salix Pharmaceuticals. Mark's educational background includes an MBA from Azusa Pacific University and participation in the Wharton Fellows Program at The Wharton School.